Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd., a well-known ophthalmic product brand under Freda Group, one of the top ten eye drop brands, is a comprehensive pharmaceutical enterprise focusing on biotechnology products and biochemical drug research
Bausch & Lomb was founded in 1853 in New York, USA. For more than 100 years, we have been committed to the research and development of optics, medicine and health care, and our products have been constantly innovating, so that consumers around the world can fully enjoy the convenience and benefits brought by scientific and technological progress to life.
Today, Bausch & Lomb is a global company with more than 15,000 employees in 35 countries. In addition to contact lenses and care products, the core business also involves ophthalmic surgical instruments, ophthalmic drugs, etc., with business in more than 100 countries and regions, and the brand is widely respected and firmly occupies a dominant position in the global market. In 1987, Bausch & Lomb began to enter China, and the business development was a great success. In 2005, Bausch & Lomb successfully controlled Shandong Chia Tai Freda Pharmaceutical Co., Ltd. and established Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
Shandong Freda Pharmaceutical Group Co., Ltd. is based on the technical support of Shandong Pharmaceutical College, based on the product development of drugs, health food and cosmetics related to human health, and has formed a comprehensive pharmaceutical enterprise group integrating science, industry and trade.
With its own intellectual property technology, the pharmaceutical group has successively established a number of high-tech enterprises such as Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd., Shandong Mingren Freda Pharmaceutical Co., Ltd., Shandong Freda Bioengineering Co., Ltd., and Shandong Freda Biotechnology Co., Ltd. The industry involves medicines, health foods, cosmetics, medical devices and APIs, etc., and has many well-known brands such as "Runshu", "Runjie", "Shi Peite", "Mingren" and "Yilian". Among them, Shandong Bausch & LombFreda Pharmaceutical Co., Ltd. has developed into the largest ophthalmic drug production base in China, and its products have occupied 20% of the domestic ophthalmic drug market share. With the technical advantages of hyaluronic acid, Shandong Freda Pharmaceutical Group's products not only occupy a major market share in the domestic market, but also are exported to Japan, the United States, Europe, South Korea and other international markets.
The pharmaceutical group consists of the pharmaceutical division and the Kangxiang Avenue division, has established a perfect sales network and customer service system in the country, pays attention to professional academic promotion and marketing, cultivates a high-quality professional sales team, and relies on the sales network to integrate the group's subordinate Chinese patent medicines, sanitary materials, medical equipment and other related resources, in the Lianghe area of Jinan High-tech Zone, relying on the existing factory of Shandong Mingren Freda Co., Ltd., relocating and expanding the other six companies. Establish a Freda Biomedical Industrial Park with a planned land area of nearly 1,000 acres.
